Archive | 2019

The ‘evil arrow’ myths and misconceptions of cancer at Lagos University Teaching Hospital, Nigeria

 
 
 
 

Abstract


Background: \xa0Myths and misconceptions have significant impact on the presentation and management of cancers globally. One such example includes ‘evil arrow’ myths. There is limited knowledge regarding the role of misconceptions in late presentation for management in developing countries. The percentage increase in cancers in many African countries is higher than that in developed countries. Evil arrow is the seeming attack of the enemy in a supernatural version as a result of wizardry. Aim: \xa0To evaluate the relationship of common myths and misconceptions among cancer patients, their treatment and delay of presentation to the hospital. Setting: \xa0The study was undertaken in a tertiary health facility in a cosmopolitan tropical state. Method: \xa0This is a randomised observational survey study carried out among patients and their relatives referred to the Radiotherapy Clinic of the Lagos University Teaching Hospital for treatment (a lower-income mixed metropolitan setting). A self-administered questionnaire was used. Patient consent was obtained. Data were analysed with Epi Info 2002 software and the results were presented using frequency tables and charts. Results: \xa0About 57 were patients (67%) and 28 were patients’ relatives (33%). The age distribution of participants showed 31–40 years (31.8%; 27) as the highest number, while 11–20 years (1.2%; 1) was the lowest number. A slight female preponderance of 58.8% (50) was observed. High incidence of those with the opinion that cause of cancer is unknown represented 63% (54). Over 65% of patients presented with advanced disease. The reasons for late presentation to the hospital included lack of funds in 23.5% of patients (20). Conclusion: \xa0Lack of funds, myths and misconception are main reasons why patients presented late to hospital. There is a need to emphasise debunking innumerable myths and misconceptions associated with cancer.

Volume 3
Pages 5
DOI 10.4102/SAJO.V3I0.49
Language English
Journal None

Full Text